M&G Investment Management’s Elanco Animal Health ELAN Stock Holding History

M&G Investment Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-186,304	Closed	-$2.24M	–	428
2022 Q4	$2.24M	Buy	186,304 +84,235	+83%	+$1.05M	0.01%	293
2022 Q3	$1.23K	Buy	+102,069	New	+$1.78M	0.01%	305

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

M&G Investment Management's ELAN Position: Q1 2023 in Review

M&G Investment Management sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 186,304 shares — an estimated $2.24M sold.

M&G Investment Management first reported a position in ELAN in Q3 2022 and held it in 2 quarters. The position peaked at $2.24M in Q4 2022. 388 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

M&G Investment Management reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
M&G Investment Management sold 186,304 Elanco Animal Health shares in Q1 2023, an estimated $2.24M.
M&G Investment Management first reported a position in Elanco Animal Health in Q3 2022 and held it in 2 quarters.
M&G Investment Management's Elanco Animal Health position peaked at $2.24M in Q4 2022.
388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on M&G Investment Management's 13F filing for Q1 2023, filed 11 May 2023.